NPPA and metabolic dysfunction-associated steatotic liver disease: Despite the increase in plasma KP and hepatic KISS1/KISS1R levels observed in a mouse model of NAFLD or in livers of patients with NAFLD, the endogenous activation of the KISS1R signaling pathway is clearly not sufficient to safeguard against disease progression.